Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06704295 · ClinicalTrials.gov registry record · NA
High Impact E-cigarette Advertisement Features
A NA study of Vaping Behavior, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 3,083
- Enrollment target
- 1
- Study location
NCT06704295: Completed NA study of Vaping Behavior, sponsored by Rutgers, The State University of New Jersey.
NCT06704295 is a NA study of Vaping Behavior that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 3,083 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (120% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06704295, a NA study of Vaping Behavior, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,083 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled trial aims to examine the effects of high-impact e-cigarette advertisement features among young adults of various tobacco-use statuses. Previous research on examining the effects of e-cigarette advertisement features found that flavor-related features (e.g., flavor-associated product color, name and image, flavor sensation descriptor, and flavor choice claim) may have the largest impact on shaping young adults' perceptions and use intentions of e-cigarettes. No research so far has solely focused on examining the effects of those high-impact flavor-related advertisement features. The present study assessed the effects of high-impact flavor-related advertisement features, including flavor descriptor name, e-cigarette product color (which indicates flavors), flavor-related image, flavor sensation descriptor, and flavor choice claim on perceptions and behavioral intentions among a large online sample of young adults aged 18-30 who either smoke cigarettes or do not use tobacco products. The study is a six-group RCT with parallel assignments that will be delivered through an online self-administered questionnaire consisting of one session. Participants will be randomly assigned to one of six trial arms: 1) dark gray product with tobacco flavor name, 2) dark gray product with strawberry flavor name, 3) colorful (strawberry color) product with strawberry flavor name, 4) colorful (strawberry color) product with strawberry flavor name and strawberry image, 5) colorful (strawberry color) product with strawberry flavor name, strawberry image, strawberry flavor sensation descriptor, and 6) colorful (strawberry color) product with strawberry flavor name, strawberry image, strawberry flavor sensation descriptor, and flavor choice claim. Participants will be exposed to one advertisement corresponding to the assigned condition, and answer survey questions immediately after message exposure.
Primary Outcome
A single item measuring the intentions of using the e-cigarette shown in the ad, assessed immediately after exposure (exposure took approximately 12 seconds). Response options are from 0 (Extremely unlikely ) to 10 (Extremely likely).
Conditions Studied
Interventions
- BEHAVIORAL Control ad with dark gray product with tobacco flavor name
- BEHAVIORAL Dark gray product with strawberry flavor name
- BEHAVIORAL Colorful (strawberry color) product with strawberry flavor name
- BEHAVIORAL Colorful (strawberry color) product with strawberry flavor name and image
- BEHAVIORAL Colorful (strawberry color) product with strawberry flavor features
Study Locations (1)
New Jersey
- Rutgers University - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,083 participants |
| Start Date | 2024-12-17 |
| Est. Completion | 2025-02-10 |
| Phase | NA |
What the finished NCT06704295 record still lists
NCT06704295 is an interventional study that assigns participants to a tested intervention. Its 3,083 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (120% higher).
The record links to 1 condition, with Vaping Behavior appearing as the primary indexed condition, and to 5 interventions - of which Control ad with dark gray product with tobacco flavor name is the first listed.
NCT06704295 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06704295 about?
NCT06704295 is a clinical study titled "High Impact E-cigarette Advertisement Features". This randomized controlled trial aims to examine the effects of high-impact e-cigarette advertisement features among young adults of various tobacco-use statuses. Previous research on examining the effects of e-cigarette advertisement features found that flavor-related features (e.g., flavor-associa...
What is the current status of trial NCT06704295?
This trial is currently completed. It is a NA study. The enrollment target is 3,083 participants. The study started on 2024-12-17. Estimated completion is 2025-02-10.
What conditions does trial NCT06704295 study?
This clinical trial studies the following conditions: Vaping Behavior.
What interventions are being tested in trial NCT06704295?
The interventions under investigation include: Control ad with dark gray product with tobacco flavor name (BEHAVIORAL), Dark gray product with strawberry flavor name (BEHAVIORAL), Colorful (strawberry color) product with strawberry flavor name (BEHAVIORAL), Colorful (strawberry color) product with strawberry flavor name and image (BEHAVIORAL), Colorful (strawberry color) product with strawberry flavor features (BEHAVIORAL).
Who is sponsoring clinical trial NCT06704295?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06704295 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06704295's enrollment target sits among peer trials
3,083 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT05051722 · 3,110 participants
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI